Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Xenoport, Inc.
xenoport, inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. horizant® (gabapentin enacarbil) extended-release tablets is approved and being marketed in the united states by xenoport. regnite® (gabapentin enacarbil) extended-release tablets is approved and being marketed in japan by astellas pharma inc. xenoport holds all other world-wide rights to gabapentin enacarbil. xenoport's pipeline of product candidates includes potential treatments for patients with parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
NAICS Code: 3254Sector: ManufacturingSub Sector: Chemical ManufacturingIndustry Group: Pharmaceutical and Medicine ManufacturingNAICS Industry: National Industry:
Frequently asked questions about Xenoport, Inc.
Let us help answer the most common questions you might have.
Where is Xenoport, Inc. located?
Xenoport, Inc.'s headquarters is located at United States
What is Xenoport, Inc.'s official website?
Xenoport, Inc.'s official website is xenoport.com
What is Xenoport, Inc.'s SIC code?
What is Xenoport, Inc.'s NAICS code?
NAICS Code: 3254Sector: ManufacturingSub Sector: Chemical ManufacturingIndustry Group: Pharmaceutical and Medicine ManufacturingNAICS Industry: National Industry:
How many employees does Xenoport, Inc. have?
Xenoport, Inc. has 115 employees
What industry does Xenoport, Inc. belong to?
Xenoport, Inc. is in the industry of: Pharmaceuticals
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free